Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 295.00
Bid: 290.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.448%)
Open: 295.00
High: 295.00
Low: 295.00
Prev. Close: 295.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

25 May 2021 19:40

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

Read more
25 May 2021 11:45

MaxCyte signs strategic partnership with Celularity

(Sharecast News) - Cell-based therapy developer MaxCyte announced the signing of a strategic platform licence with clinical-stage biotechnology company Celularity on Tuesday.

Read more
14 May 2021 14:13

IN BRIEF: MaxCyte prepares for listing in New York

IN BRIEF: MaxCyte prepares for listing in New York

Read more
14 May 2021 09:05

MaxCyte proposes dual listing on Nasdaq

(Sharecast News) - Cell engineering technology company MaxCyte has submitted a draft registration statement with the Securities and Exchange Commission (SEC), it announced on Friday, for a proposed dual-listing and public offering of shares on the Nasdaq market.

Read more
13 May 2021 19:16

IN BRIEF: MaxCyte to consolidate two lines of common stock into one

IN BRIEF: MaxCyte to consolidate two lines of common stock into one

Read more
13 May 2021 11:22

MaxCyte to consolidate two of its lines of shares

(Sharecast News) - Cell engineering company MaxCyte announced the consolidation of two of its lines of common stock into a single unrestricted line of common stock on Thursday.

Read more
20 Apr 2021 12:08

TRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss

TRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss

Read more
20 Apr 2021 09:22

MaxCyte reports good performance despite Covid challenges

(Sharecast News) - Cell engineering technology company MaxCyte reported a 21% year-on-year improvement in revenues in its final results on Tuesday, to $26.2m (£18.74m), despite the challenges of the Covid-19 pandemic.

Read more
4 Feb 2021 09:41

MaxCyte raises £40m from new and existing investors

(Sharecast News) - Cell engineering and life sciences company MaxCyte has announced a subscription to raise £40m, in a bid to strengthen its balance sheet.

Read more
3 Feb 2021 21:38

IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing

IN BRIEF: GBP40 Million MaxCyte Subscription Ahead Of Dual Listing

Read more
20 Jan 2021 17:40

LONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%

LONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%

Read more
11 Jan 2021 14:51

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

Read more
23 Dec 2020 10:36

Maxcyte Core Life Sciences Business Results To Beat Expectations

Maxcyte Core Life Sciences Business Results To Beat Expectations

Read more
23 Oct 2020 16:04

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
13 Oct 2020 14:06

UK EXECUTIVE CHANGE SUMMARY: Danakali Hires Potash Mining Vet As COO

UK EXECUTIVE CHANGE SUMMARY: Danakali Hires Potash Mining Vet As COO

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.